Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 2.657B
March 31, 2026 2.614B
December 31, 2025 2.508B
September 30, 2025 1.821B
June 30, 2025 1.757B
March 31, 2025 1.732B
December 31, 2024 1.686B
September 30, 2024 1.591B
June 30, 2024 1.517B
March 31, 2024 1.468B
December 31, 2023 1.457B
September 30, 2023 1.447B
June 30, 2023 1.248B
March 31, 2023 1.319B
December 31, 2022 1.415B
September 30, 2022 1.009B
June 30, 2022 1.067B
March 31, 2022 1.145B
December 31, 2021 1.252B
September 30, 2021 1.311B
June 30, 2021 849.96M
March 31, 2021 893.51M
December 31, 2020 957.82M
Date Value
September 30, 2020 976.71M
June 30, 2020 723.26M
March 31, 2020 558.64M
December 31, 2019 589.82M
September 30, 2019 380.25M
June 30, 2019 383.33M
March 31, 2019 261.44M
December 31, 2018 268.17M
September 30, 2018 277.31M
June 30, 2018 194.36M
March 31, 2018 218.66M
December 31, 2017 214.61M
September 30, 2017 204.06M
June 30, 2017 158.42M
March 31, 2017 176.02M
December 31, 2016 210.68M
September 30, 2016 242.38M
June 30, 2016 261.27M
March 31, 2016 265.75M
December 31, 2015 265.24M
September 30, 2015 262.37M
June 30, 2015 106.75M
March 31, 2015 120.30M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Guardant Health, Inc. 1.912B
CareDx, Inc. 532.99M
Myriad Genetics, Inc. 638.90M
BioRestorative Therapies, Inc. 4.640M
Exagen, Inc. 51.94M

Total Assets (Quarterly) Related Metrics